We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Fevertree Drinks Plc | LSE:FEVR | London | Ordinary Share | GB00BRJ9BJ26 | ORD 0.25P |
Bid Price | Offer Price | High Price | Low Price | Open Price | |
---|---|---|---|---|---|
715.00 | 716.50 | 747.00 | 702.50 | 747.00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Wine & Alcoholic Bev-whsl | 364.4M | 15.4M | 0.1319 | 54.32 | 851.01M |
Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
---|---|---|---|---|
16:35:16 | O | 2 | 710.00 | GBX |
Date | Time | Source | Headline |
---|---|---|---|
02/12/2024 | 11:47 | UK RNS | Fevertree Drinks PLC Standard form for notification of major holdings |
02/12/2024 | 07:00 | UK RNS | Fevertree Drinks PLC Block Listing Return |
02/12/2024 | 07:00 | UK RNS | Fevertree Drinks PLC Total Voting Rights |
28/11/2024 | 17:12 | UK RNS | Fevertree Drinks PLC Standard form for notification of major holdings |
18/9/2024 | 13:42 | UK RNS | Fevertree Drinks PLC Standard form for notification of major holdings |
12/9/2024 | 08:56 | ALNC | TOP NEWS: Fevertree lowers sales outlook as wet weather dampens sales |
12/9/2024 | 06:00 | UK RNS | Fevertree Drinks PLC FY24 Interim Results to 30 June 2024 |
02/9/2024 | 06:00 | UK RNS | Fevertree Drinks PLC Total Voting Rights |
01/8/2024 | 06:00 | UK RNS | Fevertree Drinks PLC Total Voting Rights |
01/7/2024 | 06:00 | UK RNS | Fevertree Drinks PLC Total Voting Rights |
Fevertree Drinks (FEVR) Share Charts1 Year Fevertree Drinks Chart |
|
1 Month Fevertree Drinks Chart |
Intraday Fevertree Drinks Chart |
Date | Time | Title | Posts |
---|---|---|---|
04/12/2024 | 13:55 | FEVER TREE with chart | 8,738 |
06/9/2024 | 19:40 | Fevertree Drinks PLC (Fever-Tree) | 1,967 |
14/8/2024 | 13:06 | Fevertree Drinks (FEVR) One to Watch on Monday | 1 |
24/11/2022 | 12:15 | Fevertree | 156 |
26/11/2021 | 11:18 | Fevertree - private investor | 971 |
Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
---|---|---|---|---|
2024-12-11 16:55:05 | 710.00 | 2 | 14.20 | O |
2024-12-11 16:35:16 | 715.00 | 100,038 | 715,271.70 | UT |
2024-12-11 16:29:50 | 716.50 | 2 | 14.33 | AT |
2024-12-11 16:29:44 | 715.75 | 13 | 93.05 | O |
2024-12-11 16:29:44 | 716.00 | 81 | 579.96 | O |
Top Posts |
---|
Posted at 11/12/2024 08:20 by Fevertree Drinks Daily Update Fevertree Drinks Plc is listed in the Wine & Alcoholic Bev-whsl sector of the London Stock Exchange with ticker FEVR. The last closing price for Fevertree Drinks was 729p.Fevertree Drinks currently has 116,736,657 shares in issue. The market capitalisation of Fevertree Drinks is £836,418,147. Fevertree Drinks has a price to earnings ratio (PE ratio) of 54.32. This morning FEVR shares opened at 747p |
Posted at 04/12/2024 13:55 by wetdream Nick Train ‘in pain’ over Diageo bet and fund performancePresumably FEVR contributing to his ‘pain’. |
Posted at 03/12/2024 23:10 by valuehurts Imagine you are selling lemonade for one pound and the prices of ingredients mugs etc go up so much you only make a penny of profit. If you get the cups a penny cheaper and raise prices by a penny your profit is now 3 pence. Your profits have tripled. Now imagine you sell 33 percent more lemonade. Your profits have quadrupled. This is the principle of how this share could work out. |
Posted at 02/12/2024 21:07 by valuehurts What's half of market cap got to do with anything? This story is about margins and the cost of bottling etc. PEs will look high if the costs increase. These types of businesses have a few levers to pull to increase earnings. Cut the operating costs, which should happen now they have made progress with the bottling. Increase pricing, which they are doing and increase volume which seem to be doing. What's special about Fevertree though is that the people who buy it aren't that price sensitive. You could increase prices quite aggressively and people would still buy it. It may even be good for the brand. |
Posted at 02/12/2024 13:37 by disc0dave46 CTNot looked at Docs for a while as seemed to be getting way ahead of itself. If this FY profits are only a third of last year that's circa 2.5p eps, so on a fairly hefty PE IMO at 27x. That said if a recovery does play out (which I can't see tbh) the forecast earnings for FY26 are 5.4p, IMO a target price of say 80p (PE 15x), but better risks to rewards out there IMO.Will trump put the boot in with his tariffs?, then there's the issues here in the UK with min wage and NI etc. |
Posted at 02/12/2024 09:14 by castleford tiger ValueHurtsNot in the first half results they were flat. last full year sales were up 20m to 364m which........ is LESS THAN HALF MARKET CAP net profit fell £10m giving a p/e of 50+ I do understand that FEVR has never looked a sensible valuation. The big concern is the UK sales are falling. Tiger |
Posted at 27/11/2024 14:35 by philanderer JPMorgan cuts Fevertree Drinks price target to 825 (900) pence - 'neutral' |
Posted at 23/11/2024 11:50 by riskvsreward It is incredible that this is a share favoured by both Smith and Train. |
Posted at 08/11/2024 22:16 by ricardo montalban Anything that cites U.K. summer weather as being a large factor is pretty fxkt….this is like worth 1.80-2 quid a share. It’s a Neil Woodford type share. |
Posted at 07/9/2024 09:59 by laurence llewelyn binliner 26.03.2024 - We are confident that the benefit of the actions taken in 2023, along with a focus on further profit-driving initiatives in 2024, including continued execution of our pricing strategy across key markets, will drive a significant improvement in gross margin in 2024 and allow for further recovery in 2025 and beyond.Now let us see how they actually performed in H1, the share price tell a different story down -50%, but potential opportunity timing if the update is positive, rate cuts widely expected on the 18th in the US.. |
Posted at 20/8/2024 09:15 by philanderer Fever-Tree can fizz again, says Deutsche BankPremium mixer business Fever-Tree (FEVR) is trading at an ‘attractive valuation’ despite the challenging backdrop, says Deutsche Bank. Analyst Deirdre Mullaney retained her ‘buy’ recommendation but reduced the target price from £16 to £14.50 on the stock, which rose 2% to 913p on Monday after a full-year preview. The shares have tumbled 9% year-to-date. Despite the downbeat sentiment towards the business, Mullaney said that she ‘continues to believe Fever-Tree is well positioned to capitalise on the long-term premium mixer opportunity given its strong brand equity and large white space opportunity overseas’. Falling costs, new supply agreements and supply chain improvements will allow ‘strong margin recovery than consensus expects in outer years’. However, Mullaney said that near-term the ‘stock will struggle given the challenging market backdrop’, leading her to revise down full-year 2024 and 2025 expectations that reflect a ‘negative weather impact over the summer and weak global spirits market’. The shares trade on 23.1 times price to earnings for 2025 which Mullaney said ‘is an attractive valuation given the long-term growth potential’. Citywire.com |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions